Family Medicine Doctors in Cohoes, NY Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Thomas Chattathil, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Mohawk St Ste 105, Cohoes, NY 12047 Phone: 518-235-7282

Dr. Russell M Zivkovich, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Bedford St, Cohoes, NY 12047 Phone: 518-237-3629

Olai Vivian Sam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 95 Remsen Street, Cohoes, NY 12047 Phone: 518-235-7282    Fax: 518-235-4274

Dr. T. Christina Antoine, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 231 Remsen St, Cohoes, NY 12047 Phone: 518-326-5340    Fax: 888-466-8655

News Archive

Study could offer new way to treat, prevent diabetes-associated blindness

Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, could offer a new way to treat and prevent a blinding eye disease caused by diabetes.

Preparis unveils new website to help businesses and employees prepare for swine flu pandemic

Preparis, Inc. today associated the rapid spread of H1N1 pandemic to the high percentage of companies that are not doing enough to prevent its spread in the workplace. In response, the company has unveiled a special website dedicated to helping businesses and their employees prepare for the "swine flu" pandemic. This free service, called H1N1 Central, takes a decidedly business-centric and hands-on approach. It can be found at www.preparis.com.

Findings may explain why HIV cure strategies have failed

A major hurdle to curing people of HIV infection is the way the virus hides in a reservoir composed primarily of dormant immune cells.

Interim progress from Phase III TeloVac study of GV1001 vaccine announced

KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.

Diamyd Medical announces European Phase III study results in type 1 diabetes

Diamyd Medical reports that results from its European Phase III study with the antigen-based therapy Diamyd did not meet the primary efficacy endpoint of preserving beta cell function at 15 months, as measured by meal stimulated C-peptide, in newly diagnosed type 1 diabetes patients.

Read more Medical News

› Verified 3 days ago